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Certain Saccharomyces cerevisiae strains produce killer toxins
which kill sensitive cells. This phenomenon is important for strains
to survive in natural and industrial populations. Toxins are able to kill
the nonkiller and different type killer yeast belonging to the same or
other genera while the producing cells remain immune to the action
of its own or relative toxins. Depending on the differences of toxins'
molecular features, killer effects and encoding genetic determinants
there are three types of killer systems: K1, K2, and K28. Among those,
the mechanism of action of K2 killer is the least understood. In order
to describe the mechanism of K2 action it is necessary to analyse not
only the intraspecial activity but also its effect on other microorgan-
isms. It is known that some yeast killer strains have antibacterial
activity but the performed microbiological tests are not sensitive
enough to determine it. Instrumental studies carried out with
susceptible yeasts and bacteria are more sensitive.
The objective of our work was the evaluation of K2 killer toxins'
impact on different microorganisms applying microbiological methods
and performing bioluminescence and electrochemical analysis to
characterise the energetical state of cells. It was shown that during the
action K2 toxin decreases the level of ATP and the gradients of small
molecules. Our study demonstrated that measurements of biolumi-
nescence and electrochemical analysis are very useful methods for
determination of the sensitivity of cells to toxin and the analysis of
killing mechanisms.
doi:10.1016/j.bbabio.2012.06.416
21P13
Melanocytes — A novel tool to study mitochondrial dysfunction in
Duchenne muscular dystrophy
C. Pellegrini, A. Zulian, F. Gualandi, E. Manzati, L. Merlini, M.E.
Michelini, L. Benassi, A. Ferlini, N.M. Maraldi, P. Bernardi, P. Sabatelli
University of Ferrara, Department of Experimental and Diagnostic
Medicine, Via Fossato di Mortara 74, I-44100 Ferrara, Italy
University of Padova, Department of Biomedical Sciences,V.le Colombo 3,
I-35121 Padova, Italy
Medicina Fisica e Riabilitazione, Dipartimento Rizzoli Sicilia,
V.le G. Bagnera 14, I-90011 Bagheria, Palermo, Italy
University of Ferrara, U.O. Chir Ped-Azienda Ospedaliera, Via Fossato di
Mortara 74, I-44100 Ferrara, Italy
E-mail: zulian.alessandra@gmail.com
Dystrophin is a subsarcolemmal protein critical for the integrity of
muscle ﬁbers by linking the actin cytoskeleton to the extracellular
matrix via the dystroglycan complex (DGC). DGC also occurs at
dermal–epidermal junction in skin. Here we report for the ﬁrst time
that epidermal melanocytes express dystrophin. The full-length
muscle isoform of dystrophin (mDp427) was clearly detectable in
skin sections as assessed by RNA analysis. Dystrophin was selectively
expressed at the basal layer of melanocytes where it co-localized with
basement membrane (BM) components. Dystrophin was absent in
the epidermis of Duchenne muscular dystrophy (DMD patients),
while dystroglycans and BM components were normally expressed.
We have characterized mitochondrial function in primary cultures
of melanocytes from one normal donor and two DMD patients.
Mitochondria readily accumulated tetramethylrhodamine methyl
ester, indicating that they are energized irrespective of the presence
of dystrophin. On the other hand, and at variance from mitochondria
of control donors, mitochondria of DMD patients readily depolarized
upon the addition of oligomycin, suggesting either that they are
maintaining the membrane potential at the expense of glycolytic ATP,
or that they are affected by a latent dysfunction unmasked by inhibition
of the ATP synthase. We are currently investigating the basis for
this anomalous response to oligomycin, which in Ullrich congenital
muscular dystrophy is caused by sensitization of the permeability
transition pore. Since melanocyte cultures can be easily obtained by
conventional skin biopsies, they represent a promising cellular model
for studying and monitoring dystrophinopathies and their response to
experimental treatments.
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Mitochondrial DNA (mtDNA) variations including single nucleo-
tide polymorphisms (SNPs) have been proposed to be involved in
idiosyncratic drug reactions. However, current in vitro and in vivo
models lack the genetic diversity seen in the human population. Our
hypothesis is that different cell strains with distinct mtDNA SNPs may
have different mitochondrial bioenergetic proﬁles and may therefore
vary in their response to drug-induced toxicity. Therefore, we used
an in vitro system composed of four strains of mouse embryonic
ﬁbroblasts (MEFs) with mtDNA polymorphisms. We sequenced
mtDNA from embryonic ﬁbroblasts isolated from four mouse strains,
C57BL/6J, MOLF/EiJ, CZECHII/EiJ and PERA/EiJ, with the latter two
being sequenced for the ﬁrst time. The bioenergetic proﬁle of the four
strains of MEFs was investigated at both passage 3 and 10. Our results
showed that there were clear differences among the four strains of
MEFs at both passages, with CZECHII/EiJ having a lower mitochon-
drial robustness when compared to C57BL/6J, followed by MOLF/EiJ
and PERA/EiJ. Seven drugs known to impair mitochondrial function
were tested for their effect on the ATP content of the four strains of
MEFs in both glucose- and galactose-containing media. Our results
showed that there were strain-dependent differences in the response
to some of the drugs. We propose that this model is a useful starting
point to study compounds that may cause mitochondrial off-target
toxicity in early stages of drug development, thus decreasing the
number of experimental animals used.
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